Agile Therapeutics, Inc. (AGRX) Social Stream
AGILE THERAPEUTICS INC (AGRX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering AGRX.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
AGRX's average price target has moved down $4.25 over the prior 19 months.
AGRX reports an average of 16,876.49% for its upside potential over the past 172 days.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
AGRX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
AGRX's average broker recommendation rating improved by 0.33 over the prior 48 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AGRX as an investment opportunity.
- In the context of all US stocks, AGILE THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 551.52% of them.
- To contextualize these metrics, consider that out of stocks in the micro market cap category, AGILE THERAPEUTICS INC's average analyst price target is higher than 574.17% of them.
- In the context of Healthcare stocks, AGILE THERAPEUTICS INC's number of analysts covering the stock is greater than 128.63% of them.
- AGILE THERAPEUTICS INC's variance in analysts' estimates is lower than -845.71% of stocks in the micro market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AGILE THERAPEUTICS INC are PHIO, ORGS, and EVOK.
View All Top Stocks by Price Target
Is AGRX a Buy, Hold or Sell? See the POWR Ratings now!